Interní Med. 2011; 13(9): 343-346

Immunostimulating therapy, its risks, benefits, and current possibilities

MUDr.Mgr.Jitka Petanová, CSc.
Ústav imunologie a mikrobiologie, 1. LF UK v Praze a VFN v Praze

Immunostimulating therapy is one of the immunointervention possibilities in patients. The indications for its use are recurrent infections

of the respiratory and gastrointestinal tracts. The aim of the immunostimulation is to increase the functions of innate and specific

immunity and to enhance patient´s immune response. Immunostimulating therapy is based on the use of different immunostimulating

agents. This therapy has some risks but it is possible to prevent them.

Keywords: immunostimulating therapy, immunoglobulins, synthetic and biologic drugs, therapy risks

Published: September 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petanová J. Immunostimulating therapy, its risks, benefits, and current possibilities. Interní Med. 2011;13(9):343-346.
Download citation

References

  1. Todd I, Spickett G. Immunological Therapy. In: Lecture notes. Immunology. Oxford: Blackwell Publishing Ltd 2005: 181-189.
  2. Chapel H, et al. Immune Manipulation. In: Essentials of Clinical Imunology. Oxford: Blackwell Publishing Ltd 2006: 125-142.
  3. Bartůňková J. Imunodeficience. Praha: Grada Publishing 2002: 232 s.
  4. Fučíková T. Imunomodulace. In: Klinická imunologie v praxi (2. vydání). Praha: Galén 1997: 280-318.
  5. Bystroň J. Recidivující infekce a možnosti jejich ovlivnění imunomodulací. Med. Pro Praxi 2010; 7(3): 115-121.
  6. Bystroň J. Imunomodulační léčba v pediatrii. Pediatr. praxi 2010; 11(5): 298-304.
  7. Jílek D. Klinické a farmakoekonomické aspekty bakteriální imunomodulace. Med. Pro Praxi 2009; 6(1): 53-54.
  8. Alecsandru D, et al. Sublingual therapeutic immunization with polyvalent bacterial preparation in patiens with recurrent respiratory infections: immunomodulatory effect of antigen-specific memory CD4+ T cells and impact on clinical outcome. Clinical and Experimental Immunology 2011; 164: 100-107. Go to original source... Go to PubMed...
  9. Steurer-Stey C, et al. Oral purified bacterial extracts in chronic bronchitis and COPD. Systematic review. Chest 2004; 126: 1645-1655. Go to original source... Go to PubMed...
  10. Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. J Pediatr 2010; 6(1): 5-12. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.